{
  "paper": {
    "doi": null,
    "pmcid": "PMC4192497",
    "title": "Therapeutic Molecules and Endogenous Ligands Regulate the Interaction between Brain Cellular Prion Protein (PrPC) and Metabotropic Glutamate Receptor 5 (mGluR5)",
    "authors": [
      "Laura T. Haas",
      "Mikhail A. Kostylev",
      "Stephen M. Strittmatter"
    ],
    "journal": null,
    "year": null,
    "study_type": "experimental",
    "eco_type": null
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "777544707e2808fd01d9cb8fbe5dc1d74b29532b",
      "git_commit_short": "7775447",
      "git_branch": "main",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:5bdf447f3cfe242d"
    },
    "execution": {
      "timestamp": "2026-02-27T16:21:23.837396Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 23.67
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "cellular_prion_protein",
      "class": "Protein",
      "name": "cellular prion protein",
      "synonyms": [
        "PrPC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "metabotropic_glutamate_receptor_5",
      "class": "Protein",
      "name": "metabotropic glutamate receptor 5",
      "synonyms": [
        "mGluR5"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "amyloid_beta_oligomers",
      "class": "Protein",
      "name": "amyloid-\u03b2 oligomers",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "alzheimer_disease",
      "class": "Disease",
      "name": "Alzheimer disease",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "prpc_region_91_153",
      "class": "Protein",
      "name": "PrPC region 91-153",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "antibodies_against_prpc_region_91_153",
      "class": "Drug",
      "name": "antibodies against PrPC region 91-153",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "agonist",
      "class": "Drug",
      "name": "agonist",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "antagonist",
      "class": "Drug",
      "name": "antagonist",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "protein_protein_interaction",
      "class": "BiologicalProcess",
      "name": "protein-protein interaction",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "paper_1:background:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "background_1",
      "text": "Amyloid-\u03b2 oligomers trigger Alzheimer disease pathophysiology via the interaction of cellular prion protein (PrPC) with metabotropic glutamate receptor 5 (mGluR5)",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:results:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_1",
      "text": "PrPC region 91\u2013153 interacts preferentially with the activated conformation of mGluR5",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:conclusion:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "conclusion_1",
      "text": "Antibodies against PrPC region 91\u2013153 and agonist/antagonist-driven mGluR5 conformations regulate the PrPC-mGluR5 interaction",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:significance:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "significance_1",
      "text": "These findings have therapeutic implications for Alzheimer disease by identifying compounds that modulate the PrPC-mGluR5 interaction",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": null,
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "amyloid_beta_oligomers",
      "predicate": "INCREASES_RISK",
      "object": "alzheimer_disease",
      "evidence_ids": [
        "paper_1:background:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "background",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "cellular_prion_protein",
      "predicate": "ASSOCIATED_WITH",
      "object": "metabotropic_glutamate_receptor_5",
      "evidence_ids": [
        "paper_1:background:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "interaction_type": "protein-protein interaction"
      },
      "section": "background",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "prpc_region_91_153",
      "predicate": "ASSOCIATED_WITH",
      "object": "metabotropic_glutamate_receptor_5",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "interaction_type": "preferential interaction with activated conformation"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "antibodies_against_prpc_region_91_153",
      "predicate": "TREATS",
      "object": "alzheimer_disease",
      "evidence_ids": [
        "paper_1:conclusion:1:llm",
        "paper_1:significance:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "mechanism": "regulation of PrPC-mGluR5 interaction"
      },
      "section": "conclusion",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "agonist",
      "predicate": "TREATS",
      "object": "alzheimer_disease",
      "evidence_ids": [
        "paper_1:conclusion:1:llm",
        "paper_1:significance:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "mechanism": "modulation of PrPC-mGluR5 interaction"
      },
      "section": "conclusion",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "antagonist",
      "predicate": "TREATS",
      "object": "alzheimer_disease",
      "evidence_ids": [
        "paper_1:conclusion:1:llm",
        "paper_1:significance:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "mechanism": "modulation of PrPC-mGluR5 interaction"
      },
      "section": "conclusion",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    }
  ],
  "notes": [
    "The paper focuses on the therapeutic potential of compounds that can modulate the PrPC-mGluR5 interaction for Alzheimer disease treatment",
    "The specific region 91-153 of PrPC appears to be critical for the interaction with mGluR5",
    "Both agonists and antagonists of mGluR5 can regulate the PrPC-mGluR5 interaction, suggesting multiple therapeutic approaches"
  ]
}